High-Margin German Medical Cannabis Platform & Licensed EU-GMP Gateway

Fully licensed, high-margin German cannabis platform offering a fully operational, plug-and-play gateway into the Germany medical cannabis market

Fully independent operations with zero reliance on third-party storage or white-label platforms

Strategically located facility with significant narcotics storage capacity, capable of storing up to 5–6 tons at any given time, enabling large-scale global importation and immediate international scalability.

Licensed for QC, batch release, and importation, with a de-risked pathway for internal EU-GMP product transformation

Established infrastructure to generate import and batch release service fees for large international groups seeking EU market access, expected to contribute several million euros in annual profitability at estimated gross margins of 80–90%

Strategic roadmap includes completion of GACP-to-EU-GMP transformation capabilities by Q2–Q3 2026, materially expanding high-margin processing revenues

Combined initiatives support a targeted 2026 revenue range of €7.0M–€9.0M

Industry-leading lean footprint with an ultra-low monthly burn rate

Low cost operation with solid financial metrics (available to qualified parties upon request)

Led by MDs and pharmaceutical veterans with deep experience at global firms

Unique hybrid model utilizing pharmacy profit-sharing and deep integration with nationwide telemedicine providers

This opportunity is ideally suited for Multi-State Operators (MSOs) and Global Licensed

Producers (LPs) looking to "plant a flag" in Germany with a de-risked, asset-backed platform that is already generating cash flow